About the Company
We do not have any company description for Absci Corp at the moment.
Exchange
NASDAQ
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ABSI News
Absci lays off 15% of workforce, revises 2023 financial outlook
Absci Corp. (Nasdaq: ABSI), the Vancouver, Washington-based AI drug creation company, is laying off 15% of its global workforce, according to a recent filing with the Securities and Exchange ...
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
and NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today reported financial and operating results for the quarter ended June ...
Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer
VANCOUVER, Wash., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Absci Corporation, a generative AI drug creation company, announced today that Zach Jonasson, Ph.D., has been appointed Chief Financial Officer ...
Absci (NASDAQ: ABSI)
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech ...
AbSci (ABSI) Receives a Buy from Berenberg Bank
See which 3 stocks are most likely to make moves following their insider activities. Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins ...
Biotech company Absci lays off 30 employees, about 15% of staff
Publicly traded biotech company Absci is laying off 30 employees, or approximately 15% of its workforce. The layoffs, revealed in a SEC filing on Tuesday, are “related to the Company’s ...
Vancouver biotech firm Absci lays off 15 percent of its worldwide staff
Local biotechnology company Absci announced earlier this week that it has laid off about 15 percent of its staff worldwide. The Vancouver-based company made the news public in an SEC filing Tuesday.
Absci to Participate in Upcoming Investor Conferences
VANCOUVER, Wash. and NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the ...
Absci Corp.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Absci Corporation (ABSI)
VANCOUVER, Wash. and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will host its first R&D Day on ...
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
VANCOUVER, Wash. and NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today reported financial and operating results for the quarter ...
Absci to Participate in Upcoming Investor Conferences
VANCOUVER, Wash. and NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the ...
Loading the latest forecasts...